Afortiori Development, who are specialists in the development and delivery of clinical trial strategies, have received notification, September 2019, of their ISO Accreditation BS EN ISO 9001 underlining their commitment to providing quality solutions, alongside their continued growth and expansion.

ISO 9001 certification is the most widely recognized international standard for quality management, focusing on how companies can enhance customer satisfaction through the effective application of the system, including processes for improvement and review. To earn the certification, Afortiori Development underwent a rigorous and thorough audit of its systems and processes, continuous improvement practices, and customer satisfaction efforts.

“This is a significant achievement for our business” said Elizabeth Ralph, Chief Operating Officer, “reflecting the high-quality standards of the team and our commitment to deliver optimum benefits to patients, alongside the clients and products we work hard to support”.

The ISO accreditation demonstrates a key milestone in the development of the business, which offers fully integrated solutions in the provision of professional services in clinical strategy planning, clinical trial planning, clinical trial management and clinical study reporting.

“This is also great news for our clients” said Ralph “providing them with fully accredited confidence in our services as we continue to help them reach their milestones for investment, regulatory approval and market access”.

Learn more about Afortiori Development: www.aftdev.com

Latest Opportunities

Impact accelerator job vacancies

Nottingham Trent University is looking to fill two place-based impact acceleration account (PBIAA) roles.  The…

Attend the launch of the West Midlands Supply Chain Transition

Funded by the UK Government and delivered by Business Growth West Midlands, in partnership with…

Industrial Doctoral Landscape Award 2024/25 funding opportunity

Apply for funding to deliver an industrial doctoral landscape award (IDLA) in the biosciences. Applications…

Latest News

Thank you and final farewell from Chris....

As many of you know I’m not a great user of LinkedIn, so to get…

Wetwipe manufacturer Guardpack secures funding for expansion into medical device manufacturing

One of the UK’s most established contract manufacturer of wet wipes and sachets, Guardpack, has…

New Chair of the MHRA

Anthony Harnden has been appointed the new Chair of the Medicine and Healthcare products Regulatory…